Proteomics and Metabolomics Seminar Series Invites Speaker Suggestions and Collaboration

To promote the use of Proteomics and Metabolomics by Mount Sinai researchers, the Dean’s CoREs and Research Resources Program is hosting a series of seminars to familiarize Icahn School of Medicine at Mount Sinai (ISMMS) users with these technologies and capabilities. Both Cores are supported through our collaboration with Stony Brook University. In February, we invited John Haley, PhD, Director of the Proteomics Center (SBU) who gave a presentation focusing on proteomics applications in cancer therapeutics.  First in the series, Dr. Haley’s presentation was well received by the ISMMS researchers, particularly by the faculty involved in cancer research.

We are reaching out to you to increase the topics for Proteomics and/or Metabolomics to a wider audience.  Please send us the names of additional speakers you would like to invite to speak on the use of these technologies and research applications.  It would also be good to know if there are specific areas of research which we should focus on for speakers (Infectious Diseases, Immunology, etc.).

Finally, please let us know if you are planning to invite any particular speaker(s) in and we can discuss partnering with you to support the cost of the visit.

Thank you for your support of the collaboration between SBU and ISMMS as we seek to make this a useful resourceful for the entire ISMMS research community. Please email your response, comments, and questions about the Proteomics/Metabolomics Seminar Series to Dr. Shekhar Patil (shekhar.patil@mssm.edu).

Accessing Stony Brook University Cores

The CoRE administration is pleased to announce the formal agreement for Stony Brook University (SBU) to provide Proteomics and Metabolomics support to the Icahn School of Medicine at Mount Sinai (ISMMS). This agreement was presented at the recent SBU / ISMMS Scientific Symposium on October 30, 2017.

At the end of November all SBU cores, including Proteomics and Metabolomics, became available to ISMMS researchers. For more information on the proteomics services provided by SBU, please visit their Proteomics Core at http://dev-office-of-scientific-affairs.pantheonsite.io/research-core-facilities/bms.

To access SBU cores, please follow these steps:

  1. Log into iLab using ISMMS url (https://ismms.corefacilities.org/account/login)
  2. Click on the “list all cores” link on the left-hand menu
  3. Select other institutions in the dropdown menu and search for Stony Brook
  4. Select the core you want to use

If you have any questions about SBU cores, please email Shekhar Patil (shekhar.patil@mssm.edu).

 

New Biorepository Search Tool Launched

The Biorepository and Pathology Core group is pleased to announce the launch of the Biospecimen Web Portal.  Investigators will now be able to perform simple to complex searches for various types of bio-specimens that have been collected over the past 10 years.

This easy to use Biospecimen search engine will allow individuals to explore the various types of tissues (and fluids) that have been collected covering a variety of organ systems and disease types.  Furthermore, through interface with our bio-specimen tracking system, investigators will begin to understand the quantity and types of specimens (i.e. formalin-fixed, paraffin-embedded, frozen) that are potentially available for their respective research studies.  Please follow the simple steps listed on our Biorepository CoRE webpage to begin your search.  All specimen requests will be prioritized based on timing of email receipt and answered by Biorepository personnel as quickly as possible.

For additional information regarding the sample inventory please contact Dr. Michael Donovan, Scientific Director (Michael.donovan@mssm.edu). For specific questions regarding use of the search tool please email: Javier.martin-fernandez@mssm.edu.

 

Resources for Drug Discovery from the Screening Lab

The Assay Development and Screening Core for Drug Discovery has announced that their resource is running on its full capacity and invited researchers to utilize it. In addition, they seek screening collaboration with their Principal Investigators. The mission of this Core is to accelerate and enhance drug discovery research through close collaboration with investigators to identify valuable targets, establish reliable assays, and perform medium to high throughput screenings of small molecule and antibody libraries. For more information, contact Jianxi Liu, Ph.D., Senior Scientist with the Drug Discovery Institute.

 

Introducing iLab!

As you may have heard, the ISMMS COREs are excited to introduce iLab’s Core Facility Management software, an online system to improve your user experience and simplify the process of ordering and billing for core service requests. The new iLab solution will replace eRAP and move the COREs into the next generation of resource management processes.

Specific benefits of implementing the iLab solution to the PI/user are:

  • Researchers can find all shared resource facilities in one central location.
  • iLab provides a consistent interface for searching resources, requesting services, and updating project progress.
  • CORE landing pages can be viewed external to the system, allowing researchers external to the institution to view services available.
  • COREs can automatically generate recharges and invoices. Charges related to core services can be posted directly to the general ledger, eliminating data re-entry, and improving data accuracy.

Additionally, ISMMS is working with iLab to integrate with:

  • Our Single Sign On (SSO) system so that users can use their ISMMS login credentials to access iLab (the same credentials used to access ISMMS email).
  • Our financial systems so that iLab can house active funds for all PIs and their lab members.

The roll-out, effective 2/1/2016, involves six (6) CORE facilities:

  • Biorepository and Research Pathology
  • Flow Cytometry
  • Human Immune Monitoring
  • Microscopy
  • Mouse Genetics
  • qPCR

Please stay tuned for additional announcements as we prepare for this exciting new era in Core Resource Management.